Generation of a new Slc20a2 knockout mouse line as in vivo model for primary brain calcification

Abstract Primary brain calcification (PBC) is a neurodegenerative disease that causes bilateral ectopic calcification in the brain. In this study, using newly generated Slc20a2 knockout (Slc20a2 −/−) mice, we establish an in vivo model for PBC. In contrast to heterozygous Slc20a2 +/− mice (9/9 anima...

Full description

Saved in:
Bibliographic Details
Main Authors: Hisaka Kurita, Hiroki Kitaura, Kazuya Nishii, Tomohiko Masaka, Kazuki Ohuchi, Masatoshi Inden, Akiyoshi Kakita, Masatake Osawa, Isao Hozumi
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Molecular Brain
Subjects:
Online Access:https://doi.org/10.1186/s13041-025-01240-8
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Primary brain calcification (PBC) is a neurodegenerative disease that causes bilateral ectopic calcification in the brain. In this study, using newly generated Slc20a2 knockout (Slc20a2 −/−) mice, we establish an in vivo model for PBC. In contrast to heterozygous Slc20a2 +/− mice (9/9 animals) showing no obvious abnormalities, the homozygous Slc20a2 −/− mice exhibited severe calcification at 11 months of age (5/5 animals). Whilst smaller in size and number, the deposits were also detectable in 5-month-old Slc20a2 −/− mice (2/2 animals). By contrast, no obvious alterations were detectable in visceral organs, including the lung, kidney, liver, and spleen. Consistently, in PBC patients, despite the systemic mineral metabolic disturbance, calcification occurs only in a brain restricted manner. Hence, these observations suggest that our mouse model is capable of recapitulating certain aspects of human PBC etiology. In summary, our data suggested the utility of an in vivo PBC mouse model in understanding the pathological mechanisms behind brain calcification, which leads in development of novel therapeutics against PBC.
ISSN:1756-6606